These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Prostacyclins and the development and treatment of arteriosclerosis]. Szczeklik A Kardiol Pol; 1980; 23(7):537-46. PubMed ID: 6999208 [No Abstract] [Full Text] [Related]
4. [Therapeutic effect of prostacyclins in stenocardia and myocardial infarction]. Markov KhM Klin Med (Mosk); 1988 Oct; 66(10):6-14. PubMed ID: 3070155 [No Abstract] [Full Text] [Related]
6. [Prostacyclins and myocardial infarct]. Szczeklik A Pol Tyg Lek; 1983 Apr; 38(15):449-51. PubMed ID: 6356083 [No Abstract] [Full Text] [Related]
7. Clinical studies on the vasodilating and anti-platelet effects of OP-41483, a prostacyclin derivative. Kusaba A; Shiroma H; Shrestha DR; Koja K; Kina M; Kuniyoshi Y; Iha K; Kinjo O; Akasaki M; Kugai T Jpn J Surg; 1991 Jan; 21(1):8-13. PubMed ID: 2041246 [TBL] [Abstract][Full Text] [Related]
8. Prostacyclin in the therapy of peripheral arterial disease. Szczeklik A; Gryglewski RJ; Nizankowski R; Szczeklik J; Skawiński S; Głuszko P Adv Prostaglandin Thromboxane Res; 1980; 7():687-9. PubMed ID: 6989195 [No Abstract] [Full Text] [Related]
9. Prostacyclin and atherosclerosis. Szczeklik A Triangle; 1980; 19(2):61-7. PubMed ID: 7003851 [No Abstract] [Full Text] [Related]
10. [Prostaglandins and arteriosclerosis. Action of PGI 2 (PGX) on platelet aggregation]. Messini M; Messini F Clin Ter; 1979 Jul; 90(1):3-9. PubMed ID: 394908 [No Abstract] [Full Text] [Related]
11. Prostacyclin and vascular disease. Gryglewski RJ; Szczeklik A; Zygulska-Mach H; Kostka-Trabka E Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):383-8. PubMed ID: 6117899 [TBL] [Abstract][Full Text] [Related]
12. [Significance of prostaglandins in arterial thrombosis pathology: survey of an ongoing experience]. Duvivier A; David JL Rev Med Liege; 1984 May; 39(9):354-61. PubMed ID: 6203155 [No Abstract] [Full Text] [Related]
14. Prostacyclin in the treatment of atherosclerosis obliterans and other vascular diseases. Gryglewski RJ; Szczeklik A Adv Exp Med Biol; 1984; 164():211-3. PubMed ID: 6364708 [No Abstract] [Full Text] [Related]
15. [Prostacyclin (PGX, PGI2)-vascular anti-aggregation hormone regulating hemostasis]. Feldman R Pol Arch Med Wewn; 1980 Jul; 64(1):57-67. PubMed ID: 6999470 [No Abstract] [Full Text] [Related]
16. The evolution of ideas in prostaglandin research. Gryglewski RJ; Vane JR Mater Med Pol; 1980; 12(3):159-68. PubMed ID: 7019587 [No Abstract] [Full Text] [Related]
17. [Prospects of antiaggregant therapy in prevention of atherosclerosis]. Strano A; Novo S G Ital Cardiol; 1979; 9(1):5-9. PubMed ID: 396163 [No Abstract] [Full Text] [Related]
18. [Use of prostaglandins in extracorporeal circulation and hemodialysis]. Zaorska B Pol Tyg Lek; 1981 Jun; 36(23):857-60. PubMed ID: 7024949 [No Abstract] [Full Text] [Related]